Explore our new website! Designed to better serve patients, partners and the Crinetics community in the next generation of endocrinology care.

News & Events

Show:
April 11, 2025

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

Event Date: Crinetics Pharmaceuticals to report first quarter 2025 financial results and provide a business update on May 8, 2025 after market close.

READ MORE
April 10, 2025

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics granted non-qualified stock option awards to purchase an aggregate of 124,950 shares of its common stock and an aggregate...

READ MORE
March 27, 2025

Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly

Crinetics announces European Medicines Agency Validation of Marketing Authorization Application and Orphan Drug Designation for paltusotine in acromegaly.

READ MORE
March 10, 2025

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics granted non-qualified stock option awards to purchase an aggregate of 95,675 shares of its common stock to fifteen new...

READ MORE
February 27, 2025

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update.

READ MORE
February 24, 2025

Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer

Crinetics company announces the appointment of Tobin Schilke as chief financial officer, effective February 28, 2025.

READ MORE
February 20, 2025

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

Crinetics' company management will participate in the TD Cowen 45th Annual Healthcare Conference on March 3, and the Leerink Global...

READ MORE
February 20, 2025

2025 Leerink Global Healthcare Conference

Event Date: March 10, 2025

READ MORE
February 10, 2025

Crinetics Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics granted non-qualified stock option awards to purchase an aggregate of 105,100 shares of its common stock and granted an...

READ MORE
February 6, 2025

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Event Date: February 27, 2025

READ MORE